Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Hematology

Patients' Decision-Making, Experiences and Preferences Regarding Pixantrone Treatment in Relapsed Aggressive B-Cell Lymphoma: Research Protocol for a Longitudinal Qualitative Study

Hematological Oncology

English

Combination of Irak4 (Ca-4948) and BTK (Vecabrutinib) Inhibitors Show Superior Efficacy in Preclinical Models of Abc DLBCL Tumors Containing Myd88 -L265p Mutations

Hematological Oncology

English

What Can We Learn Regarding Immunotherapy From Lung Cancer

Hematological Oncology

English

Interim Data From the First Clinical Study of Adct-301, a Novel Pyrrolobenzodiazapine-Based Antibody Drug Conjugate, in Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma

Hematological Oncology

English

Advances and Challenges in the Management of Essential Thrombocythemia

Therapeutic Advances in Hematology

Hematology

2015

English

Changes in Concentration of Serum Free Light Chains of Immunoglobulins in Patients With Chronic Lymphocytic Leukemia as a Factor for Evaluating Chemotherapy Effectiveness

Hematological Oncology

English

A Phase Ii Study of Lenalidomide and Rituximab (R²) Combination in Patients With High-Risk Refractory/Relapsed Diffuse Large B-Cell Lymphoma

Hematological Oncology

English

Prognostic Value of Baseline FDG Pet Parameters in High Risk Diffuse Large B-Cell Lymphoma Patients

Hematological Oncology

English

Clinicopathological Differences of Nodal PTCL With TFH Phenotype From Aitl and Ptcl, Nos, and Detection of Prognostic Marker of Nodal PTCL With TFH Phenotype

Hematological Oncology

English

Kir3dl2 Is Expressed in Peripheral T-Cell Lymphomas and May Be a Therapeutic Target

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Hematology

Patients' Decision-Making, Experiences and Preferences Regarding Pixantrone Treatment in Relapsed Aggressive B-Cell Lymphoma: Research Protocol for a Longitudinal Qualitative Study

Combination of Irak4 (Ca-4948) and BTK (Vecabrutinib) Inhibitors Show Superior Efficacy in Preclinical Models of Abc DLBCL Tumors Containing Myd88 -L265p Mutations

What Can We Learn Regarding Immunotherapy From Lung Cancer

Interim Data From the First Clinical Study of Adct-301, a Novel Pyrrolobenzodiazapine-Based Antibody Drug Conjugate, in Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma

Advances and Challenges in the Management of Essential Thrombocythemia

Changes in Concentration of Serum Free Light Chains of Immunoglobulins in Patients With Chronic Lymphocytic Leukemia as a Factor for Evaluating Chemotherapy Effectiveness

A Phase Ii Study of Lenalidomide and Rituximab (R²) Combination in Patients With High-Risk Refractory/Relapsed Diffuse Large B-Cell Lymphoma

Prognostic Value of Baseline FDG Pet Parameters in High Risk Diffuse Large B-Cell Lymphoma Patients

Clinicopathological Differences of Nodal PTCL With TFH Phenotype From Aitl and Ptcl, Nos, and Detection of Prognostic Marker of Nodal PTCL With TFH Phenotype

Kir3dl2 Is Expressed in Peripheral T-Cell Lymphomas and May Be a Therapeutic Target